Correlation Between Achilles Therapeutics and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Capricor Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Capricor Therapeutics.
Diversification Opportunities for Achilles Therapeutics and Capricor Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Achilles and Capricor is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Capricor Therapeutics
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.4 times more return on investment than Capricor Therapeutics. However, Achilles Therapeutics PLC is 2.5 times less risky than Capricor Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 99.00 in Achilles Therapeutics PLC on August 29, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Capricor Therapeutics
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Capricor Therapeutics |
Achilles Therapeutics and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Capricor Therapeutics
The main advantage of trading using opposite Achilles Therapeutics and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |